Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,230
-160 (-1.11%)
At close: Jul 16, 2026
Market Cap448.36B -21.3%
Revenue (ttm)572.95B -4.5%
Net Income34.91B
EPS1,137.71
Shares Out 31.51M
PE Ratio12.51
Forward PEn/a
Dividend200.00 (1.41%)
Ex-Dividend DateMar 30, 2026
Volume76,523
Open14,170
Previous Close14,390
Day's Range14,010 - 14,410
52-Week Range13,150 - 45,050
Beta0.85
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements